Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.74 USD | -1.89% | -4.26% | -39.93% |
May. 15 | HC Wainwright Adjusts Fennec Pharmaceuticals Price Target to $15 From $18, Maintains Buy Rating | MT |
May. 14 | Transcript : Fennec Pharmaceuticals Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-39.93% | 188M | |
+12.18% | 116B | |
+12.76% | 106B | |
-9.40% | 23.89B | |
-1.69% | 21.58B | |
-10.60% | 18.96B | |
-41.25% | 16.96B | |
-15.28% | 16.33B | |
+6.27% | 14.14B | |
+30.01% | 12.02B |
- Stock Market
- Equities
- FENC Stock
- News Fennec Pharmaceuticals Inc.
- Fennec Pharmaceuticals Brief: Cited Pro forma fourth quarter cash in excess of US$55 million